Overexpression of CXCR4 predicts adverse overall and event‐free survival in patients with unmutated <i>FLT3</i> acute myeloid leukemia with normal karyotype
Sergej Konoplev(The University of Texas MD Anderson Cancer Center), L. Jeffrey Medeiros(Delaware Division of Libraries), Georgios Z. Rassidakis(Karolinska University Hospital), Xuelin Huang(The University of Texas MD Anderson Cancer Center), Elihu H. Estey(University of Washington), Lianchun Xiao(The University of Texas MD Anderson Cancer Center), Michael Andreeff(The University of Texas MD Anderson Cancer Center), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center), Chrysoula I. Liakou(The University of Texas MD Anderson Cancer Center), Marina Konopleva(Albert Einstein College of Medicine)
Cited by 156
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k